{"nct_id":"NCT00251589","title":"A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)","status":"TERMINATED","status_verified_date":"2015-02","start_date":"2006-01","start_date_type":null,"primary_completion_date":"2007-10","primary_completion_date_type":"ACTUAL","completion_date":"2007-10","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}